- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Service Médecine Nucléaire Caen, France
Clinical trial condition
Squamous Cell Carcinoma of the Head and Neck
Explore clinical trials studying Squamous Cell Carcinoma of the Head and Neck. Study availability and eligibility vary by location and protocol.
116 public trials
11 recruiting studies
Squamous Cell Carcinoma of the Head and Neck trial results
NCT01012258
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Fujian Provincial Tumor Hospital Fuzhou, Fujian, China
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, China
- Xiangya Hospital of Central South University Changsha, Hunan, China
- Sun Yat-sen University Cancer Center Guangzhou, China
NCT00206752
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Beth Israel Medical Center New York, United States
Completed
Cabazitaxel - PF Induction Chemotherapy
NCT01379339
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Cancer Institute & Hospital, Chinese Academy of Medical Sciences Beijing, China
- Jilin Cancer Hospital Changchun, China
- The Xiangya 2nd Hospital of Central South University Changsha, China
- Fuijan Provincial Tumor Hospital Fuijian, China
NCT00971932
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Research Site Aichi, Japan
- National Cancer Center East Hospital Chiba, Japan
- Research Site Ehime, Japan
- Research Site Hokkaido, Japan
Completed
Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)
NCT00206219
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Tucson, Arizona, United States
- Research Site Palm Springs, California, United States
- Research Site Aurora, Colorado, United States
Active, Not Recruiting
VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Head and Neck Cancer
NCT03690986
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Emory University Hospital Midtown Atlanta, Georgia, United States
Active, Not Recruiting
Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy
NCT03712566
- Conditions
- Anal Canal Squamous Cell Carcinoma, Cancer, Carcinoma, +22 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
Active, Not Recruiting
Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer
NCT04590963
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +9 more
- Locations
-
- Research Site Tucson, Arizona, United States
- Research Site Chicago, Illinois, United States
- Research Site Westwood, Kansas, United States
- Research Site Boston, Massachusetts, United States